Professor of Drug delivery, University of Geneva, Switzerland
Associate Professor of Drug delivery, Universite de Montreal, Canada
Group Website: https://farma-unites.unige.ch/fr/brambilla-lab
Davide BRAMBILLA - Faculté de pharmacie - Université de Montréal
Davide Brambilla is Professor of Drug Delivery at the University of Geneva, Switzerland and Faculty of Pharmacy at the Unviersity of Montreal, Canada. He completed his Ph.D. in Pharmaceutical Technologies and Biopharmacy at the School of Pharmacy, University of Paris-Sud, focusing on the design of nanoparticles for drug delivery applications. In 2012, he joined ETH Zurich, where, after three years as a postdoctoral researcher, was promoted to Group Leader. In 2017, he was appointed Assistant Professor at the Université de Montréal, promoted to Associate Professor in 2022, and in 2026, became Professor at the University of Geneva. His laboratory focuses on the design of nanoparticles for drug delivery applications and microneedles for diagnostic purposes. In 2023, he received the New Investigator Research Award from the Association of Faculties of Pharmacy of Canada. He has co-authored over 100 publications in leading peer-reviewed journals (Science Advances, Nature Sensors, Advanced Materials, Small, Biomaterials, Journal of Controlled Release), filed two patents, and co-founded a start-up company. He is a past president of the Canadian Chapter of the Controlled Release Society and serves as an Associate Editor of the Journal of Controlled Release.
Representative Publications
1. DePLIT: Photoluminescence Lifetime Imaging Thermo-dermoscopy Enables Early-stage Diagnosis of Micro-melanoma. Y. Lai, A. N. Argüello, M. Liu, M. Soulez, F. Vetrone*, S Meloche*, D Brambilla*, J. Liang*. Nature Sensor, 1-13, 2026.
2. Lipid-based nanoparticles deliver mRNA to reverse the pathogenesis of lysosomal acid lipase deficiency in a preclinical model. Zadory M, Lopez E, Haddouche H, Kenaan El Rahbani RM, Vujic N, Kratky D, Gravel SP, Brambilla D. Nature Communications, Revisions Submitted.
3. Metabolic microenvironment-forming porous hydrogels for the protection of phenylalanine ammonia-lyase in the intestine, Biomaterials, 2025, 123942
4. Rational Design of a New Class of Versatile Enzyme-Based Biosensors. S Pei, S Dhondt, S Babity, D Brambilla. Analytical Chemistry 2025, 97-12 6638-50
5. Integrating microneedles and sensing strategies for diagnostic and monitoring applications: the state of the art. S. Pei, S Babity, AS Cordeiro, D Brambilla. Advanced Drug Delivery Reviews, 2024, 210, 115341.
6. Therapeutic nanotechnologies for Alzheimer’s disease: a critical analysis of recent trends and findings. P Delbreil, JM Rabanel, X Banquy, D Brambilla. Advanced Drug Delivery Reviews, 2022. 187, 114397.
